The identification of genetic causes of ALS will help develop new therapeutic approaches, either through the identification of shared disease pathways such as the TDP-43 pathology or by targeted therapies for known mutations [222]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.